Skip to content
Case report Open access

p.(V142I)-Associated Variant Transthyretin Amyloid Cardiomyopathy Complicating Complex Congenital Heart Disease

Aug 2026 · JACC Case Reports · Vol 31, pp. 109784 · 0 citations · 10 references
Medicine

TL;DR

This unusual case highlights the diagnostic pitfalls when genetics, adult congenital heart disease, and advanced heart failure intersect and a high index of suspicion for p.(V142I)-ATTRv-CM is needed to prompt early diagnosis and initiation of disease-modifying therapies.

Abstract

Background p.(V142I)-associated variant transthyretin amyloid cardiomyopathy (ATTRv-CM) is biologically aggressive and predominantly affects individuals of African ancestry. Case Summary A 51-year-old Nigerian man was diagnosed with double outlet right ventricle by the adult congenital heart disease service, although challenging social circumstances hindered adherence to clinic appointments. He re-established regular contact after 3 years and underwent workup for corrective surgery. Cardiac amyloidosis was suspected on repeat echocardiogram and confirmed on cardiac magnetic resonance and bone scintigraphy. Genetic sequencing later identified homozygosity for the p.(V142I) transthyretin variant. He was referred for emergency transplant assessment after developing cardiogenic shock. Unfortunately, he died despite receiving supportive therapies. Discussion Homozygous p.(V142I)-ATTRv-CM presents earlier and advances more aggressively than its heterozygous counterpart. This unusual case highlights the diagnostic pitfalls when genetics, adult congenital heart disease, and advanced heart failure intersect. Take-Home Message In patients of African ancestry, a high index of suspicion for p.(V142I)-ATTRv-CM is needed to prompt early diagnosis and initiation of disease-modifying therapies.

Read PDF

Similar papers

Case report Open access Sep 2026

Clinical Benefit of the Transthyretin Stabiliser Tafamidis in Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report.

AIMS/BACKGROUND This case report aims to illustrate the critical importance of a standardized diagnostic approach and genotype-specific therapy in hereditary transthyretin amyloid cardiomyopathy (ATTR-CM). It highlights the clinical challenge of diagnosing ATTR-CM amidst complex comorbidities and addresses the evidence...

Xing Xiao, Meng-Chen Yang, Ling Ding · 0 citations
Case report Open access Sep 2026

Transthyretin Amyloidosis Due to a Rare TTR Val142del Deletion With Relatively Early Clinical Manifestations

Background Hereditary transthyretin amyloidosis shows marked phenotypic heterogeneity. In-frame deletions at codon 142 are exceedingly rare, and their cardiac expression remains poorly characterized. Case Summary A 62-year-old man presented with progressive neuropathy, autonomic dysfunction, weight loss, and recurrent...

C. Espinoza Romero, K. De Paula Morales, Christiane Espirito Santo et al. · 0 citations
Case report Open access Sep 2026

TTR Variant p.Ala65Val Causing Early-Onset Hereditary Transthyretin Amyloidosis With Mixed Cardiac and Neuropathic Phenotype

Background Variant transthyretin amyloidosis (ATTRv) remains undercharacterized in Latin America, with limited awareness of its regional mutational diversity. Case Summary A 48-year-old Peruvian man presented with syncope, exertional dyspnea, weight loss, and lower extremity paresthesia. Multimodality evaluation demons...

Javier Torres-Valencia, Sebastian Reyes-Villanes, Elder Quispe et al. · 0 citations
Case report Open access Sep 2026

Rare Hereditary Cardiac Amyloidosis Treated With SGLT2 Inhibitor

Background Rare hereditary cardiac amyloidosis (CA) may mimic transthyretin or light-chain cardiomyopathy, and reports for effective therapy in these entities are limited. Case Summary A 61-year-old man presented with progressive heart failure (NYHA functional class III). Medical history included bilateral carpal tunne...

J. Voran, Željka Radić, L. Kilian et al. · 0 citations
Open access Sep 2026

Case Report: Fabry cardiomyopathy associated with a novel truncating GLA variant, c.837_838delinsAT, p.(Gln280Ter)

We report the comprehensive clinical characterization of a woman with Fabry disease (FD) carrying a previously unreported truncating GLA variant, c.837_838delinsAT, p.(Gln280Ter). The patient, a 52-year-old woman with longstanding hypertrophic cardiomyopathy, was referred to a specialized Fabry Disease Program to i...

F. Perretta, E. Zurita, M. Ortiz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.